Latest Biotech News

Researchers at Chuo University have pioneered a microfluidics-based methodology for the high-throughput fabrication of artificial cells containing model DNA condensates mimicking eukaryotic...

Cutting-edge studies illuminate molecular and cellular mechanisms relevant to brain aging, PTSD, and Parkinson’s disease. Research at Salk Institute highlights neuron-to-glia communication...

Research and development progress in cancer therapeutics is marked by innovative strategies targeting tumor biology and microenvironments. Genentech describes inhibitors targeting KRAS G12D...

Groundbreaking genetic and epigenetic advances offer new therapeutic avenues and insights into disease mechanisms. Hubrecht Institute researchers report a method to reactivate silenced genes by...

Innovative vaccine approaches employing synergistic adjuvant combinations and antibody engineering demonstrate breakthrough efficacy. Research teams at MIT and the Scripps Research Institute...

FDA Commissioner Martin Makary announced a pilot program offering expedited review vouchers for drugs addressing U.S. national priorities, aiming to reduce approval times from 10-12 months down to...

The FDA approved Gilead Sciences’ lenacapavir (Yeztugo), a long-acting injectable for HIV pre-exposure prophylaxis administered twice annually. Clinical trials demonstrated near-complete...

Recent advances encompass enhanced CAR T-cell therapies, novel antibody-drug conjugates, and precision molecular assays. Research at MD Anderson characterized lymphoma subtypes affecting CD19 CAR...

The integration of AI continues to reshape multiple biotech domains—from accelerating green ammonia catalyst discovery at UNSW Sydney to enabling personalized nutrition guidance in oncology. UTA...

Chuo University researchers achieved landmark mass production of artificial cells containing model nuclei using microfluidic platforms, replicating eukaryotic DNA condensate structures with...

Studies unravel mechanisms of resistance to therapies and immune modulation in cancer. UT Health San Antonio received $3.4M CPRIT funding to combat drug-resistant cancers using CRISPR and degrader...

Advances include early pain network development characterization in newborns, Parkinson’s prodromal imaging, and enhanced DBS modeling for gait improvement. New non-invasive Parkinson’s diagnostic...

Caris Life Sciences’ IPO raised $494 million to expand its comprehensive molecular profiling and AI-driven cancer diagnostics, leveraging data from over 6.5 million tests. Its assays support...

New research reveals the impact of wildfire smoke and heat stress on adverse birth outcomes in climate-vulnerable populations. Precision agriculture advances include novel AI and sensor-based...

The biotech sector faces uncertainty amid fluctuating tax policies, tariffs, and interest rates, impacting investment and growth as noted by EY analysts. HHS cancellations of biotech grants tied...

The Food and Drug Administration has approved Gilead Sciences’ lenacapavir (Yeztugo), a long-acting injectable drug administered twice yearly to prevent HIV infection in at-risk adults and...

FDA Commissioner Martin Makary outlined an ambitious vision for a "New FDA" emphasizing streamlined drug approvals, integration of AI and big data, and enhanced partnership with industry. At the...

Groundbreaking studies using single-cell transcriptomics in human brain tissue have revealed crucial disruptions in cellular communication associated with PTSD, including diminished signaling from...

A team led by Professor Hiroaki Suzuki at Chuo University has developed a microfluidic-based method to mass-produce uniform artificial lipid bilayer vesicles containing DNA condensates serving as...

Recent studies reveal critical mechanisms of drug resistance and novel therapeutic strategies across multiple cancers. UT Health San Antonio researchers uncovered the CST complex’s role in PARP...